GRAIL’s Multi-Cancer Early Detection Test Gets Added to Insurance Plan
Galleri can identify DNA shed by cancer cells to help screen for some of the deadliest cancers that don’t have recommended screening today.
Read MorePosted by Andy Lundin | Feb 2, 2024 | Cancer |
Galleri can identify DNA shed by cancer cells to help screen for some of the deadliest cancers that don’t have recommended screening today.
Read MorePosted by Andy Lundin | Feb 2, 2024 | Cytology |
The cytology system combines AI with advanced volumetric imaging technology to identify pre-cancerous lesions and cervical cancer cells.
Read MorePosted by Andy Lundin | Jan 31, 2024 | Cancer |
The genetic test evaluates specific genes that offer individuals insights into their genetic profiles and their effects on health and aging.
Read MorePosted by Andy Lundin | Jan 26, 2024 | Melanoma |
DermaSensor Inc. announced FDA clearance for its real-time, non-invasive skin cancer evaluation system which detects common skin cancers.
Read MorePosted by Andy Lundin | Jan 25, 2024 | Digital Pathology |
New research has led to the U.K. government approving the use of digital pathology to help speed up the analysis of cancer screening samples.
Read More